654 related articles for article (PubMed ID: 31098627)
1. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A.
Barile L; Cervio E; Lionetti V; Milano G; Ciullo A; Biemmi V; Bolis S; Altomare C; Matteucci M; Di Silvestre D; Brambilla F; Fertig TE; Torre T; Demertzis S; Mauri P; Moccetti T; Vassalli G
Cardiovasc Res; 2018 Jun; 114(7):992-1005. PubMed ID: 29518183
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
[TBL] [Abstract][Full Text] [Related]
5. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
[TBL] [Abstract][Full Text] [Related]
6. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.
Horie T; Ono K; Nishi H; Nagao K; Kinoshita M; Watanabe S; Kuwabara Y; Nakashima Y; Takanabe-Mori R; Nishi E; Hasegawa K; Kita T; Kimura T
Cardiovasc Res; 2010 Sep; 87(4):656-64. PubMed ID: 20495188
[TBL] [Abstract][Full Text] [Related]
7. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
[TBL] [Abstract][Full Text] [Related]
9. Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal
Li X; Liao J; Su X; Li W; Bi Z; Wang J; Su Q; Huang H; Wei Y; Gao Y; Li J; Liu L; Wang C
Theranostics; 2020; 10(21):9561-9578. PubMed ID: 32863945
[No Abstract] [Full Text] [Related]
10. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
11. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.
Altomare C; Lodrini AM; Milano G; Biemmi V; Lazzarini E; Bolis S; Pernigoni N; Torre E; Arici M; Ferrandi M; Barile L; Rocchetti M; Vassalli G
Front Physiol; 2021; 12():658790. PubMed ID: 33897465
[TBL] [Abstract][Full Text] [Related]
12. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
[TBL] [Abstract][Full Text] [Related]
13. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
[TBL] [Abstract][Full Text] [Related]
15. The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.
Hsu WT; Huang CY; Yen CYT; Cheng AL; Hsieh PCH
Theranostics; 2018; 8(12):3176-3188. PubMed ID: 29930721
[No Abstract] [Full Text] [Related]
16. Exosomal Micro-RNA-96 Derived From Bone Marrow Mesenchymal Stem Cells Inhibits Doxorubicin-Induced Myocardial Toxicity by Inhibiting the Rac1/Nuclear Factor-κB Signaling Pathway.
Lei B; Wu X; Xia K; Sun H; Wang J
J Am Heart Assoc; 2021 Sep; 10(17):e020589. PubMed ID: 34459233
[TBL] [Abstract][Full Text] [Related]
17. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
[TBL] [Abstract][Full Text] [Related]
18. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4.
Xiao J; Pan Y; Li XH; Yang XY; Feng YL; Tan HH; Jiang L; Feng J; Yu XY
Cell Death Dis; 2016 Jun; 7(6):e2277. PubMed ID: 27336721
[TBL] [Abstract][Full Text] [Related]
19. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
[TBL] [Abstract][Full Text] [Related]
20. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
Fu Q; Pan H; Tang Y; Rong J; Zheng Z
Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
